Tag: outlook

A look at ethics in orthopedics
Top Stories

A look at ethics in orthopedics

Three years ago, the Board of the European Federation of National Associations of Orthopaedics and Traumatology set up an ethics committee. The first aim of the committee was to prepare a document outlining how ethical considerations should apply in the very different countries of our federation. Its second aim was […]

BioRestorative Therapies Provides Company Updates With Shareholder Letter
Biologics

BioRestorative Therapies Provides Company Updates With Shareholder Letter

MELVILLE, N.Y., Dec. 21, 2015 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc. (the “Company”) (OTCBB:BRTX), a life sciences company focused on stem cell-based therapies, today announced the issuance of a shareholder letter by Chief Executive Officer, Mark Weinreb, providing an update to shareholders on the Company’s progress, the text of which […]

MiMedx Provides 2016 Guidance With Forecasted Revenue Growth In Excess Of 30% And Operating Earnings Growth Of 80% Or Greater
Financial

MiMedx Provides 2016 Guidance With Forecasted Revenue Growth In Excess Of 30% And Operating Earnings Growth Of 80% Or Greater

MARIETTA, Ga., Dec. 16, 2015 /PRNewswire/ — MiMedx Group, Inc. (NASDAQ:  MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic, and Dental sectors of healthcare, announced today its outlook for 2016. […]

Zacks Industry Outlook Highlights: Bayer, Abbott Laboratories, Roche Holding, Medtronic and Johnson & Johnson
Financial

Zacks Industry Outlook Highlights: Bayer, Abbott Laboratories, Roche Holding, Medtronic and Johnson & Johnson

Chicago, IL – December 04, 2015 – Today, Zacks Equity Research discusses the MedTech (Part 1), including Bayer AG, Abbott Laboratories, Roche Holding AG, Medtronic plc, and Johnson & Johnson. Despite the socio-economic and political instability prevailing in most geographic markets at present, the MedTech industry overall has so far witnessed a […]

Orthofix International Reports Second Quarter 2015 Financial Results
Financial

Orthofix International Reports Second Quarter 2015 Financial Results

LEWISVILLE, Texas–(BUSINESS WIRE)–Orthofix International N.V. (NASDAQ:OFIX) today reported its financial results for the second quarter ended June 30, 2015, including net sales of $101.0 million, diluted earnings per share from continuing operations of $0.21 and adjusted diluted earnings per share of $0.36. “I am pleased with our second quarter results and the […]

NCAA Football - Duke vs. Wake Forest - Groves Stadium - Saturday, September 9, 2006

Wake Forest 14 - Duke 13
Sports Medicine

The Long-Term Outlook for European Sports Medicine Device Markets Remains Positive, with Economic Recovery and Expanding Patient Populations Supporting Growth Through 2023

BURLINGTON, Mass., July 29, 2015 /PRNewswire/ — Decision Resources Group finds that the sports medicine device market in Europe will continue to be hindered in the near term by unfavorable economic conditions across the Eurozone. On a longer timeline, however, the outlook is improved. Expanding populations of the elderly, obese, and physically active will increase the […]

MiMedx Reports Record First Quarter 2015 Revenue of $40.8 Million
Financial

MiMedx Reports Record First Quarter 2015 Revenue of $40.8 Million

MARIETTA, Ga., April 13, 2015 /PRNewswire/ — MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic and Dental sectors of healthcare, pre-announced today its record revenue results for […]

Moody’s: U.S. medical device firms face soft organic growth prospects
Financial

Moody’s: U.S. medical device firms face soft organic growth prospects

By Stewart Eisenhart, Emergo Group U.S. medical device manufacturers dealing with lower market demand and rising pricing pressure will rely more on acquisitions and stock maneuverings to offset challenging growth prospects. Moody’s Investor Service (via MarketWatch) anticipates slow sales for medical device firms over the next 12 to 18 months—especially for devices […]